The purpose of this study is the use of Nefazodone in the treatment of cocaine dependence and depression comorbidity.
The objective of this study is to determine the safety and efficacy of nefazodone (Serzone ) in depressed cocaine dependent subjects. This is a hypothesis-testing study which will explore whether cocaine usage will be reduced in the nefazodone treatment group compared to a placebo control group.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
69
All subjects attended a weekly 1-hour therapy session during the 8 week treatment period.
Boston University
Boston, Massachusetts, United States
Urine benzoylecgonine (BE) concentration
Natural log BE in urine samples collected weekly were analyzed for the baseline week and the subsequent 8 treatment weeks.
Time frame: Study Weeks Basekine to Week 8
Hamilton Depression Scale (HAM-D)
HAM-D collected on a weekly basis.
Time frame: Baseline through Study Week 8
Cocaine-Craving Scale
CCS scores were collected on a weekly basis.
Time frame: Baseline through Week 8
Adverse Events Self Report
Data for adverse events were collected on a weekly basis
Time frame: Study Weeks 1 through 8
Alcohol Drug Use Inventory
Subjects were asked about the amount of cocaine consumed and the number of days in cocaine was used in the previous week, on a weekly basis.
Time frame: Baseline through Study Week 8
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.